Radiation Therapy
- Cancer Home
- Patient-Centered Cancer Care
-
Cancer Types
- Brain and Central Nervous System Cancers
- Breast Cancers
- Gastrointestinal Cancer
- Genitourinary Cancers
- Gynecologic Cancer
- Head and Neck Cancers
- Leukemias, Lymphomas, and Myelomas
- Liver and Bile Duct Cancers
- Lung Cancers and Mesothelioma
- Melanoma and Skin Cancers
- Sarcoma (Bone and Soft Tissue Cancers)
- Cancer Screening
- Cancer Treatment Options
- Cancer Support Services
- Infusion Therapy
- Radiation Therapy
State-of-the-art Equipment and Technology
Learn more about...
Gamma Knife
The Leksell Gamma Knife® Icon™ (LGKI) gives clinicians the option to perform single or fractionated frame-based or frameless radiation therapy treatments, allowing for more individualized delivery without sacrificing precision and accuracy.
Versa HD
Versa HD—our premium system—delivers absolute reliability, accuracy and confidence in stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) treatments, to help you grow your stereotactic program as a mainstream technique. Confidently treat complex or challenging cancers with submillimeter, end-to-end accuracy.
IORT (Intraoperative Radiation Therapy)
ZEISS INTRABEAM 600 ensures local precision during tumor bed sterilization, as time matters, directly combining surgery and irradiation into one step, rounded up by proven performance with a strong evidence base in radiotherapy for truly personalized treatments.
Microseletron HDR
Our Microseletron HDR unit along with the Venezia applicator system enables our clinicians to treat locally advanced cervical cancers with interstitial brachytherapy. This technology allows for a pre-defined and reproducible treatment delivery, ensuring optimal dose distribution for our patients.
Hexapod Robotic Couch
Six degree patient positioning robotic couch completes the IGRT localization chain by enabling accurate correction of misalignment before treatment delivery. This allows clinicians to reduce margins with confidence, escalate dose and move towards hypofractionated treatment regimes.